Schott Pharma AG KGaA (WBO:1SXP) Cash And Cash Equivalents : €16.8 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Cash And Cash Equivalents?

Schott Pharma AG KGaA's quarterly cash and cash equivalents increased from Jun. 2024 (€22.15 Mil) to Sep. 2024 (€23.18 Mil) but then stayed the same from Sep. 2024 (€23.18 Mil) to Dec. 2024 (€16.78 Mil).

Schott Pharma AG KGaA's annual cash and cash equivalents declined from Sep. 2022 (€28.80 Mil) to Sep. 2023 (€24.36 Mil) and declined from Sep. 2023 (€24.36 Mil) to Sep. 2024 (€23.18 Mil).

Schott Pharma AG KGaA Cash And Cash Equivalents Historical Data

The historical data trend for Schott Pharma AG KGaA's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Cash And Cash Equivalents Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

Cash And Cash Equivalents

18.61

27.86

28.80

24.36

23.18

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial							21.34	19.02	22.15	23.18	16.78

Schott Pharma AG KGaA Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Schott Pharma AG KGaA (WBO:1SXP) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Schott Pharma AG KGaA Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

SHTPY:USA 1SXP:Italy 1SXPd:UK 1SXP:Germany

Address

Hattenbergstrasse 10, Mainz, RP, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines